121 related articles for article (PubMed ID: 16865209)
21. Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients.
Pelizzo MR; Boschin IM; Toniato A; Piotto A; Pagetta C; Gross MD; Al-Nahhas A; Rubello D
Clin Nucl Med; 2007 Jun; 32(6):440-4. PubMed ID: 17515749
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome.
Woo DK; Jones CR; Vanoli-Storz MN; Kohler S; Reddy S; Advani R; Hoppe RT; Kim YH
Arch Dermatol; 2009 Jun; 145(6):667-74. PubMed ID: 19528422
[TBL] [Abstract][Full Text] [Related]
23. Papillary thyroid carcinoma: factors influencing recurrence and survival.
Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
[TBL] [Abstract][Full Text] [Related]
24. Serum albumin as a significant prognostic factor for patients with gastric carcinoma.
Oñate-Ocaña LF; Aiello-Crocifoglio V; Gallardo-Rincón D; Herrera-Goepfert R; Brom-Valladares R; Carrillo JF; Cervera E; Mohar-Betancourt A
Ann Surg Oncol; 2007 Feb; 14(2):381-9. PubMed ID: 17160496
[TBL] [Abstract][Full Text] [Related]
25. Surgical volume influences survival in patients undergoing resections for stage II colon cancers.
Morris M; Platell CF
ANZ J Surg; 2007 Oct; 77(10):902-6. PubMed ID: 17803560
[TBL] [Abstract][Full Text] [Related]
26. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
28. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival.
Oddone N; Morgan GJ; Palme CE; Perera L; Shannon J; Wong E; Gebski V; Veness MJ
Cancer; 2009 May; 115(9):1883-91. PubMed ID: 19224549
[TBL] [Abstract][Full Text] [Related]
29. Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Br J Surg; 2007 May; 94(5):571-7. PubMed ID: 17279493
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors determining survival in differentiated thyroid cancer.
Gulcelik MA; Gulcelik NE; Kuru B; Camlibel M; Alagol H
J Surg Oncol; 2007 Dec; 96(7):598-604. PubMed ID: 17708543
[TBL] [Abstract][Full Text] [Related]
31. Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base.
Bilimoria KY; Bentrem DJ; Rock CE; Stewart AK; Ko CY; Halverson A
Dis Colon Rectum; 2009 Apr; 52(4):624-31. PubMed ID: 19404066
[TBL] [Abstract][Full Text] [Related]
32. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
33. Papillary thyroid microcarcinoma: prognostic factors and treatment.
Besic N; Pilko G; Petric R; Hocevar M; Zgajnar J
J Surg Oncol; 2008 Mar; 97(3):221-5. PubMed ID: 18050283
[TBL] [Abstract][Full Text] [Related]
34. Tumour budding at invasive margins and outcome in colorectal cancer.
Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
[TBL] [Abstract][Full Text] [Related]
35. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
Lin JD; Chao TC; Chen ST; Huang YY; Liou MJ; Hsueh C
Surg Oncol; 2007 Aug; 16(2):107-13. PubMed ID: 17600699
[TBL] [Abstract][Full Text] [Related]
36. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
37. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
39. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
40. Ten-year follow-up of a province-wide cohort of surgical lung cancer patients in Nova Scotia.
Wong DR; Henteleff HJ
Can J Surg; 2008 Aug; 51(4):257-62. PubMed ID: 18815647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]